Unapproved drops for dry eyes pose risks: Govt
Semaglutide Patent Expires: Will Diabetes, Weight-Loss Treatment Become More Accessible For Patients?
Inaugural Conference of ‘Critical Nephrology Society of India’ (CNSI) puts Best Foot Forward
Govt highlights multi-layer framework to curb misleading advertisements
Major breakhthrough: Sonbhadra cops nab codeine syrup racket handler in Bengal
Study finds rising resistance to a last-resort antibiotic in Africa
Patna: Over 20,000 Banned Injections Seized in Ramkrishna Nagar Area, One Arrested
Pharma Company Bus Overturns in Miyapur, 10 Employees Injured, Probe Underway
India regulator asks states to implement uniform drug licensing norms to end quality gaps
Sale of fake obesity drugs driven by high prices, weight-loss desire prompts health concernGujarat companies eye Uzbekistan
AHMEDABAD: Gujarat-based companies are actively exploring investment opportunities in pharmaceuticals and textile sectors in Uzbekistan as the central Asian country offers them huge potential. “There is huge scope for pharma…
Bristol-Myers gets $1.6 bln offer for French consumer health unit
Bristol: Myers Squibb Co received an offer from Japanese healthcare firm Taisho Pharmaceutical Holdings Co Ltd to buy the company’s French over-the-counter drugs business UPSA for $1.6 billion, the companies…
Eli Lilly sees 2019 profit, revenue above estimates; shares rise
Eli Lilly and Co on Wednesday forecast better-than-expected revenue and adjusted profit for 2019, as the drugmaker benefits from higher demand for its newer medicines including diabetes drug Trulicity and…
Medicinal drug seizures go up, arrests come down
CHANDIGARH: The seizure of banned injectable vials and intoxicatant tablets have gone up this year as compared to last year. From January 1 to December 18, cops recovered 4,081 banned…
J&J says Indian drug regulators visited facilities, company provided talc samples
By Rahul Singh NEW DELHI: Johnson & Johnson said on Wednesday that Indian drugs authorities visited some of its facilities and it provided them with “tests and samples” of its…
Government prohibits distribution, sale of Buclizine as ‘appetite stimulant’
New Delhi: The Union Health Ministry has prohibited the distribution and sale of anti-histamine drug Buclizine as an appetite stimulant “in public interest” under the Drugs and Cosmetics Act. The…
Generico raises $3m in Series A funding
NEW DELHI: Generico, a Mumbai-based pharmacy retail startup exclusively selling low-cost generic medicines, has raised $3 million in Series A funding from early stage investment funds Tomorrow Capital and Whiteboard…
Price caps on drugs helped patients save Rs 11.5k cr: Government
Mumbai: Price caps on 856 essential medicines fixed by the National Pharmaceutical Pricing Authority (NPPA) have resulted in savings of Rs 11,462 crore for patients, said minister of state for…
Pharma industry returns on R&D investment hit 9-year low
LONDON: The cost of developing a new drug has nearly doubled since 2010 and the world’s 12 biggest drugmakers are making the lowest return on their R&D investments in nine…
3.36% of about 82,600 drugs samples found to be substandard
As many as 2,783 samples or 3.36 per cent of the total 82,599 samples tested by drug controllers of various states and Union Territories in 2017-18 were declared substandard, Parliament…